Apple Unveils M3 Chips in Updated MacBook Air; Preorder and Learn More Info at B&H
Apple introduced the new MacBook Air 13– and 15-inch versions with dramatically increased performance speed and battery life. NEW YORK–(BUSINESS WIRE)–#Apple–B&H... Read more.
FireMon Unveils Revamped Ignite Partner Program
New enhancements and educational initiatives promise to strengthen partnerships and customer solutions in network security management. LENEXA, Kan.–(BUSINESS... Read more.
Momentus Awarded NASA Contract to Provide Flight and Payload Integration Services
SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS)(“Momentus” or the “Company”), a leading provider of in-space transportation services,... Read more.
Canadian Marketers in Transition and Marketers from Under-Represented Groups to Receive High-Demand Skills Training Through Innovative New Platform
TORONTO–(BUSINESS WIRE)–Today, the Canadian Marketing Association is announcing the launch of the Digital Marketing Skills Canada (DMSC) program. The... Read more.
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
SARASOTA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment... Read more.
American Express Global Business Travel Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Introduces 2024 Outlook
NEW YORK–(BUSINESS WIRE)–American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”... Read more.
Hemophilia B Pipeline Insight Report 2024: Comprehensive Analysis of Emerging Therapeutics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hemophilia B – Pipeline Insight, 2024” report has been added to ResearchAndMarkets.com’s offering.... Read more.
Monro, Inc. Appoints Jack Heisman as Vice President – Human Resources
ROCHESTER, N.Y.–(BUSINESS WIRE)–Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced that... Read more.
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
– First PAH Patient Dosed in Ongoing Registrational Phase 3 PROSERA Study – – Inclusion of Japan in Phase 3 PROSERA Study Following CTN Acceptance... Read more.
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
– Study Met the Primary Endpoint Demonstrating Clinically Significant Systolic Blood Pressure Reductions at Month 3 When Zilebesiran Was Added to a Diuretic, Calcium-Channel... Read more.